Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Valérie Capra

Showing results (1-10 of 32) with videos related to

Pageof 4
Sort By:
Pharmacological Research|April 15, 2004
Molecular and functional aspects of human cysteinyl leukotriene receptorsValérie Capra
Idrugs : the Investigational Drugs Journal|July 10, 2004
Leukotriene modifiers in asthma managementValérie Capra, G Enrico Rovati
Pulmonary Pharmacology & Therapeutics|June 29, 2013
Rosuvastatin inhibits human airway smooth muscle cells mitogenic response to eicosanoid contractile agentsValérie Capra, G Enrico Rovati
Thescientificworldjournal|September 4, 2007
Cysteinyl-leukotriene receptors and cellular signalsG Enrico Rovati, Valérie Capra
Current Drug Targets|April 15, 2010
Leukotrienes and atherosclerosisGraziano Riccioni, Magnus Bäck, Valérie Capra
Molecular Pharmacology|December 29, 2006
The highly conserved DRY motif of class A G protein-coupled receptors: beyond the ground stateG Enrico Rovati, Valérie Capra, Richard R Neubig
American Journal of Respiratory Cell and Molecular Biology|January 1, 2005
Thromboxane prostanoid receptor signals through Gi protein to rapidly activate extracellular signal-regulated kinase in human airwaysSimona Citro, Saula Ravasi, G Enrico Rovati, et al.
Respiratory Research|March 24, 2006
CysLT1 receptor-induced human airway smooth muscle cells proliferation requires ROS generation, EGF receptor transactivation and ERK1/2 phosphorylationSaula Ravasi, Simona Citro, Barbara Viviani, et al.
Biochemical Pharmacology|May 9, 2002
Pharmacological differences among CysLT(1) receptor antagonists with respect to LTC(4) and LTD(4) in human lung parenchymaSaula Ravasi, Valérie Capra, Tiziana Panigalli, et al.
Trends in Pharmacological Sciences|February 2, 2010
Dual COXIB/TP antagonists: a possible new twist in NSAID pharmacology and cardiovascular riskG Enrico Rovati, Angelo Sala, Valérie Capra, et al.
Pageof 4

Showing results (1-10 of 32) with videos related to

Sort By:
Pageof 4
Pharmacological Research|April 15, 2004
Molecular and functional aspects of human cysteinyl leukotriene receptorsValérie Capra
Idrugs : the Investigational Drugs Journal|July 10, 2004
Leukotriene modifiers in asthma managementValérie Capra, G Enrico Rovati
Pulmonary Pharmacology & Therapeutics|June 29, 2013
Rosuvastatin inhibits human airway smooth muscle cells mitogenic response to eicosanoid contractile agentsValérie Capra, G Enrico Rovati
Thescientificworldjournal|September 4, 2007
Cysteinyl-leukotriene receptors and cellular signalsG Enrico Rovati, Valérie Capra
Current Drug Targets|April 15, 2010
Leukotrienes and atherosclerosisGraziano Riccioni, Magnus Bäck, Valérie Capra
Molecular Pharmacology|December 29, 2006
The highly conserved DRY motif of class A G protein-coupled receptors: beyond the ground stateG Enrico Rovati, Valérie Capra, Richard R Neubig
American Journal of Respiratory Cell and Molecular Biology|January 1, 2005
Thromboxane prostanoid receptor signals through Gi protein to rapidly activate extracellular signal-regulated kinase in human airwaysSimona Citro, Saula Ravasi, G Enrico Rovati, et al.
Respiratory Research|March 24, 2006
CysLT1 receptor-induced human airway smooth muscle cells proliferation requires ROS generation, EGF receptor transactivation and ERK1/2 phosphorylationSaula Ravasi, Simona Citro, Barbara Viviani, et al.
Biochemical Pharmacology|May 9, 2002
Pharmacological differences among CysLT(1) receptor antagonists with respect to LTC(4) and LTD(4) in human lung parenchymaSaula Ravasi, Valérie Capra, Tiziana Panigalli, et al.
Trends in Pharmacological Sciences|February 2, 2010
Dual COXIB/TP antagonists: a possible new twist in NSAID pharmacology and cardiovascular riskG Enrico Rovati, Angelo Sala, Valérie Capra, et al.
Pageof 4